Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD
Sep 6, 2020
Race for coronavirus vaccine pits spy against spy
The pandemic has prompted one of the fastest peacetime mission shifts in recent times for the world's intelligence agencies, pitting them against one another.
Japan Times
WORLD / Science & Health
Sep 3, 2020
COVID-19 vaccine front-runners will soon see their moment of truth
Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn't create severe risks.
Japan Times
ASIA PACIFIC / Science & Health
Sep 2, 2020
Vaccine front-runner held back by China’s spat with Canada
One of the world’s fastest-moving efforts to develop a COVID-19 vaccine is falling behind rivals, its advance appearing to be stymied by political tensions between China and Canada and concerns its shot may not work as well as others.
Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
JAPAN / Society
Aug 28, 2020
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
WORLD / Science & Health
Aug 16, 2020
Coronavirus crisis has made Brazil an ideal vaccine laboratory
With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.
Japan Times
COMMENTARY / World
Aug 10, 2020
Vaccine confronts humanity with next moral test
Who gets coronavirus protection first (and last)? Who profits (and loses)? What is “informed consent” (if it exists)? Divided societies face agonizing choices.
Japan Times
COMMENTARY / World
Aug 5, 2020
Pricing COVID-19 vaccines too high could backfire on big pharma
If vaccine makers make their products too expensive for the developing world, the whole idea of intellectual property could be blown up.
Japan Times
JAPAN
Aug 4, 2020
Gargle medicine can fight coronavirus, Osaka governor says, citing limited data
The governor of Osaka Prefecture touted the powers of gargling medicine to control the coronavirus and recommended its use, sending related shares jumping and clearing shelves of disinfectants even as some questioned the findings.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
WORLD / Science & Health
Jul 30, 2020
Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12
The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?